Canaccord Genuity Group Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN) had its price objective decreased by analysts at Canaccord Genuity Group from $20.00 to $15.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the construction company’s stock. Canaccord Genuity Group’s price target would suggest a potential upside of 73.09% from the stock’s current price.

Several other research firms also recently weighed in on ASPN. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Saturday, February 8th. Roth Mkm cut their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Seaport Res Ptn downgraded shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Craig Hallum lowered their price objective on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday. Finally, Barclays lowered their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Aspen Aerogels presently has an average rating of “Moderate Buy” and an average target price of $24.67.

Aspen Aerogels Stock Down 3.7 %

Shares of ASPN opened at $8.67 on Friday. The firm has a market capitalization of $711.05 million, a P/E ratio of 867.47 and a beta of 2.14. Aspen Aerogels has a 12-month low of $8.25 and a 12-month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The firm has a fifty day moving average price of $12.17 and a 200-day moving average price of $18.46.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. Equities research analysts expect that Aspen Aerogels will post 0.12 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Lord Abbett & CO. LLC acquired a new position in Aspen Aerogels during the third quarter worth approximately $10,126,000. Oppenheimer & Co. Inc. boosted its stake in shares of Aspen Aerogels by 167.2% in the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock valued at $2,839,000 after buying an additional 64,154 shares in the last quarter. Sanders Morris Harris LLC boosted its stake in shares of Aspen Aerogels by 337.5% in the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after buying an additional 27,000 shares in the last quarter. Penserra Capital Management LLC purchased a new stake in shares of Aspen Aerogels in the third quarter valued at approximately $1,342,000. Finally, Geode Capital Management LLC boosted its position in Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after purchasing an additional 75,024 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.